Liver transplantation (LT) candidates today are increasingly older, have greater medical
acuity, and have more cardiovascular comorbidities than ever before. Steadily rising model …

Involvement of the cardiovascular system in patients with end-stage liver disease (ESLD) is
well recognized and may be seen in several scenarios in adult liver transplantation (LT) …

Moderate to severe portopulmonary hypertension (PPHTN) increases the risks of orthotopic
liver transplantation (OLT). Epoprostenol is an effective treatment of PPHTN, but long‐term …

Introduction Acute cellular rejection (ACR) is a significant cause of morbidity and graft failure
in liver transplant recipients (LTR). Diastolic dysfunction (DD) is frequently present in …

Objectives of this study were (1) to evaluate preoperative predictors of systolic and diastolic
heart failure in patients undergoing liver transplantation (LT) and (2) to describe the …

Approximately 8000 liver transplants (LTs) are performed in the United States every year for
patients with fulminant liver failure or end-stage liver disease (ESLD). 1 The survival rates …

BACKGROUND: During exercise, pulmonary artery systolic pressure (PASP) may increase.
The purpose of this study was to examine the responses of PASP and pulmonary vascular …

In recent decades, important advances have been made in the field of liver transplantation.
One of the major problems remaining in this area is the small number of donors. Thus …

Abstract Porto-pulmonary hypertension (POPH), once considered an absolute
contraindication for liver transplantation (LT), has become a more accepted indication …

Patients with end stage liver disease (ESLD) have complex problems such as cirrhotic
cardiomyopathy, coronary artery disease, hepatopulmonary syndrome (HPS) …